Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

GlaxoSmithKline PLC Director's Dealing 2016

Feb 16, 2016

5262_dirs_2016-02-16_904a441e-5cb9-4967-b691-5c21659bde3f.html

Director's Dealing

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 2472P

GlaxoSmithKline PLC

16 February 2016

GlaxoSmithKline plc

Notification of Transactions of Directors, Persons Discharging Managerial   Responsibility or Connected Persons

GlaxoSmithKline Performance Share Plan

Sale of shares to meet tax liabilities

The table below sets out changes in the interests of a Person Discharging Managerial Responsibilities' ('PDMR') Connected Person in the Ordinary Shares of GlaxoSmithKline plc arising from the sale of Ordinary Shares at a fair market value price of £14.06 per Ordinary Share on 12 February 2016 to meet tax liabilities following the vesting of awards granted in 2012 under the GlaxoSmithKline 2009 Performance Share Plan ('PSP').

Name of PDMR Name of Connected Person Number of Ordinary Shares sold to meet tax liabilities following the vesting of a PSP award
Mr P Thomson Mrs K Thomson 633

The table below sets out changes in the interests of a Director's Connected Person in the American Depositary Shares ('ADS') of GlaxoSmithKline plc arising from the withholding of ADS at a fair market value price of $39.15 per ADS on 12 February 2016 to meet tax liabilities following the vesting of an award granted in 2012 under PSP.

Name of Director Name of Connected Person Number of ADSs withheld to meet tax liabilities following the vesting of a PSP award
Dr M Slaoui Dr K Slaoui 386

The Company and the above individual were advised of this transaction on 16 February 2016.      

This notification relates to a transaction notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(c).

V A Whyte

Company Secretary

16 February 2016

This information is provided by RNS

The company news service from the London Stock Exchange

END

RDSQQLFFQLFFBBE